ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMS Ims Health Holdings, Inc.

31.34
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Ims Health Holdings, Inc. NYSE:IMS NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 31.34 0 01:00:00

IMS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of IMS Health Holdings, Inc. (IMS) Over the Proposed...

05/05/2016 4:30pm

Business Wire


IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more IMS HEALTH HOLDINGS, INC. Charts.

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of IMS Health Holdings, Inc. (“IMS” or the “Company”) (NYSE:IMS) for potential breaches of fiduciary duties in connection with the sale of the Company to Quintiles Transnational Holdings, Inc. for approximately $8.75 billion.

The Company’s stockholders will only receive 0.3840 Quintiles shares for each share of Company common stock they own, equivalent to $24.94 per share of IMS. However, the offer is below at least one analyst’s price target for IMS stock at $32.00 per share.

Click here for more information: www.faruqilaw.com/IMS. There is no cost or obligation to you.

The investigation focuses on whether IMS’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of IMS’s shareholders.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

If you own common stock in IMS and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/IMS or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2016 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Faruqi & Faruqi, LLP685 Third Avenue, 26th FloorNew York, NY 10017Attn: Juan Monteverde, Esq.jmonteverde@faruqilaw.comToll Free: 877-247-4292Phone: 212-983-9330

1 Year IMS HEALTH HOLDINGS, INC. Chart

1 Year IMS HEALTH HOLDINGS, INC. Chart

1 Month IMS HEALTH HOLDINGS, INC. Chart

1 Month IMS HEALTH HOLDINGS, INC. Chart

Your Recent History

Delayed Upgrade Clock